Randall Kaye - Feb 8, 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CMO
Signature
/s/ Andrew J. Cronauer, Attorney-In-Fact
Stock symbol
LBPH
Transactions as of
Feb 8, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 04:11 PM
Previous filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LBPH Common Stock Award $0 +17.9K $0.00 17.9K Feb 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +108K $0.00 108K Feb 8, 2024 Voting common stock 108K $19.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount represents restricted stock units that vest in four equal annual installments commencing on February 8, 2025. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
F2 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 8, 2024.